Ulinastatin Improves and Prevents Cardiac Dysfunction Induced by Cardiopulmonary Bypass

Clinical trial NCT05534802 · COMPLETED

Trial details

NCT number: NCT05534802
Sponsor: Qin Zhang
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Pharmacological Action

Start date: 2022-09-16
Primary completion: 2024-12-30
Enrollment: 236

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.